JP2022515331A5 - - Google Patents
Info
- Publication number
- JP2022515331A5 JP2022515331A5 JP2021531836A JP2021531836A JP2022515331A5 JP 2022515331 A5 JP2022515331 A5 JP 2022515331A5 JP 2021531836 A JP2021531836 A JP 2021531836A JP 2021531836 A JP2021531836 A JP 2021531836A JP 2022515331 A5 JP2022515331 A5 JP 2022515331A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- amino acid
- hla
- acid sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024070994A JP2024105344A (ja) | 2018-12-19 | 2024-04-25 | 多量体ｔ細胞調節ポリペプチド及びその使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862782205P | 2018-12-19 | 2018-12-19 | |
| US62/782,205 | 2018-12-19 | ||
| US201962814707P | 2019-03-06 | 2019-03-06 | |
| US62/814,707 | 2019-03-06 | ||
| PCT/US2019/067280 WO2020132138A1 (en) | 2018-12-19 | 2019-12-18 | Multimeric t-cell modulatory polypeptides and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024070994A Division JP2024105344A (ja) | 2018-12-19 | 2024-04-25 | 多量体ｔ細胞調節ポリペプチド及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022515331A JP2022515331A (ja) | 2022-02-18 |
| JP2022515331A5 true JP2022515331A5 (enExample) | 2022-12-26 |
| JP7481342B2 JP7481342B2 (ja) | 2024-05-10 |
Family
ID=71100346
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531836A Active JP7481342B2 (ja) | 2018-12-19 | 2019-12-18 | 多量体ｔ細胞調節ポリペプチド及びその使用方法 |
| JP2024070994A Pending JP2024105344A (ja) | 2018-12-19 | 2024-04-25 | 多量体ｔ細胞調節ポリペプチド及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024070994A Pending JP2024105344A (ja) | 2018-12-19 | 2024-04-25 | 多量体ｔ細胞調節ポリペプチド及びその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20220389079A1 (enExample) |
| EP (1) | EP3897746A4 (enExample) |
| JP (2) | JP7481342B2 (enExample) |
| KR (1) | KR20210104700A (enExample) |
| CN (1) | CN113286621A (enExample) |
| AU (1) | AU2019401183B2 (enExample) |
| BR (1) | BR112021011838A2 (enExample) |
| CA (1) | CA3113096A1 (enExample) |
| IL (1) | IL282250A (enExample) |
| MX (1) | MX2021007479A (enExample) |
| TW (1) | TWI856048B (enExample) |
| WO (1) | WO2020132138A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110325205B (zh) | 2016-12-22 | 2023-08-15 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| KR20240005989A (ko) | 2017-03-15 | 2024-01-12 | 큐 바이오파마, 인크. | 면역 반응을 조절하는 방법 |
| WO2019051127A1 (en) | 2017-09-07 | 2019-03-14 | Cue Biopharma, Inc. | MULTIMER MODULATOR POLYPEPTIDE OF LYMPHOCYTE T HAVING CONJUGATION SITES AND METHODS OF USE THEREOF |
| EP3897746A4 (en) * | 2018-12-19 | 2022-10-26 | Cue Biopharma, Inc. | MULTIMERIC T LYMPHOCYTE MODULATING POLYPEPTIDES AND METHODS OF USE THEREOF |
| IL293978A (en) | 2019-12-20 | 2022-08-01 | Regeneron Pharma | New il2 agonists and methods of using them |
| IL296209A (en) | 2020-05-12 | 2022-11-01 | Cue Biopharma Inc | Multimeric t-cell modulatory polypeptides and methods of using them |
| WO2022056015A1 (en) * | 2020-09-09 | 2022-03-17 | Cue Biopharma, Inc. | Mhc class ii t-cell modulatory multimeric polypeptides and methods of use thereof |
| JP2023541366A (ja) * | 2020-09-09 | 2023-10-02 | キュー バイオファーマ， インコーポレイテッド | １型真性糖尿病（ｔ１ｄ）を治療するためのｍｈｃクラスｉｉ ｔ細胞調節多量体ポリペプチド及びその使用方法 |
| TW202317623A (zh) | 2021-06-14 | 2023-05-01 | 美商再生元醫藥公司 | 基於il2之治療劑及其使用方法 |
| US20260097105A1 (en) * | 2022-09-30 | 2026-04-09 | The Children's Hospital Of Philadelphia | Systems, formulations and methods for generating universal peptide/mhc complexes with engineered disulfide connecting the heavy and light chains |
| WO2026125765A1 (en) | 2024-12-13 | 2026-06-18 | Immunoscape Pte. Ltd. | Combination therapy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6652932B2 (ja) * | 2014-06-18 | 2020-02-26 | アルバート アインシュタイン カレッジ オブ メディシン | ｓｙｎＴａｃポリペプチド及びその使用 |
| ES2774380T3 (es) * | 2014-08-29 | 2020-07-20 | Hoffmann La Roche | Politerapia de inmunocitocinas de variante de IL-2 dirigida a tumor y anticuerpos frente a PD-L1 humano |
| WO2017008844A1 (en) * | 2015-07-14 | 2017-01-19 | Biontech Ag | Peptide mimotopes of the cd3 t-cell co-receptor epsilon chain and uses thereof |
| SG11201808552XA (en) * | 2016-05-18 | 2018-10-30 | Cue Biopharma Inc | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CN110325205B (zh) * | 2016-12-22 | 2023-08-15 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| EP3897746A4 (en) * | 2018-12-19 | 2022-10-26 | Cue Biopharma, Inc. | MULTIMERIC T LYMPHOCYTE MODULATING POLYPEPTIDES AND METHODS OF USE THEREOF |
| KR20220015382A (ko) * | 2019-05-29 | 2022-02-08 | 큐 바이오파마, 인크. | 다량체 t-세포 조절 폴리펩타이드 및 이의 사용 방법 |
| JP2022536581A (ja) * | 2019-06-19 | 2022-08-18 | キュー バイオファーマ， インコーポレイテッド | 多量体ｔ細胞調節性ポリペプチド及びその使用方法 |
| CN114599674A (zh) * | 2019-10-23 | 2022-06-07 | 库尔生物制药有限公司 | T细胞调节嵌合分子及其使用方法 |
-
2019
- 2019-12-18 EP EP19899240.6A patent/EP3897746A4/en active Pending
- 2019-12-18 JP JP2021531836A patent/JP7481342B2/ja active Active
- 2019-12-18 WO PCT/US2019/067280 patent/WO2020132138A1/en not_active Ceased
- 2019-12-18 MX MX2021007479A patent/MX2021007479A/es unknown
- 2019-12-18 CN CN201980080704.5A patent/CN113286621A/zh active Pending
- 2019-12-18 CA CA3113096A patent/CA3113096A1/en active Pending
- 2019-12-18 AU AU2019401183A patent/AU2019401183B2/en active Active
- 2019-12-18 BR BR112021011838-1A patent/BR112021011838A2/pt unknown
- 2019-12-18 TW TW108146527A patent/TWI856048B/zh not_active IP Right Cessation
- 2019-12-18 KR KR1020217017809A patent/KR20210104700A/ko not_active Ceased
-
2021
- 2021-04-12 IL IL282250A patent/IL282250A/en unknown
- 2021-05-21 US US17/327,171 patent/US20220389079A1/en not_active Abandoned
-
2024
- 2024-04-25 JP JP2024070994A patent/JP2024105344A/ja active Pending
- 2024-09-20 US US18/891,753 patent/US20250092113A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020533273A5 (enExample) | ||
| IL272085B2 (en) | Multimeric t-cell modulatory polypeptides and methods of use thereof | |
| KR102488477B1 (ko) | 신속하고 포괄적인 t-세포 면역 모니터링을 위한 세포 플랫폼 | |
| AU2013295652B2 (en) | Engineering T-cell receptors | |
| JP2021500855A5 (enExample) | ||
| JP2020514375A5 (enExample) | ||
| KR102528977B1 (ko) | 펩타이드-hla 복합체 및 그 제조 방법 | |
| JP7481342B2 (ja) | 多量体ｔ細胞調節ポリペプチド及びその使用方法 | |
| JP2022515330A5 (enExample) | ||
| JP2021500855A (ja) | 抗原提示ポリペプチドおよびその使用方法 | |
| JP2020511136A5 (enExample) | ||
| JP2022536581A5 (enExample) | ||
| JP2023526723A5 (enExample) | ||
| US20250283037A1 (en) | Methods for stimulating and transducing t cells | |
| JP2023500574A5 (enExample) | ||
| JP2021532742A5 (enExample) | ||
| JP2022522404A (ja) | Ｔ細胞調節抗原提示ポリペプチド及びその使用方法 | |
| Clement et al. | Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide–MHCI tetramer staining | |
| Zhang et al. | The effect of adjuvanting cancer vaccines with herpes simplex virus glycoprotein D on melanoma-driven CD8+ T cell exhaustion | |
| Liang et al. | A single TCRα-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoire | |
| CA3201767A1 (en) | Compositions and methods for cellular immunotherapy | |
| JP2023532278A5 (enExample) | ||
| CN117222421A (zh) | T细胞调节多肽和其使用方法 | |
| CN112105650A (zh) | 一种嵌合单链分子及其应用 | |
| Lyu et al. | A novel and simple method to produce large amounts of recombinant soluble peptide/major histocompatibility complex monomers for analysis of antigen-specific human T cell receptors |